HK1198919A1 - Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases -1 - Google Patents

Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases -1

Info

Publication number
HK1198919A1
HK1198919A1 HK14112433.4A HK14112433A HK1198919A1 HK 1198919 A1 HK1198919 A1 HK 1198919A1 HK 14112433 A HK14112433 A HK 14112433A HK 1198919 A1 HK1198919 A1 HK 1198919A1
Authority
HK
Hong Kong
Prior art keywords
antitrypsin
alpha
pulmonary diseases
exacerbation episodes
treating exacerbation
Prior art date
Application number
HK14112433.4A
Other languages
English (en)
Chinese (zh)
Inventor
Shabtai Bauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1198919A1 publication Critical patent/HK1198919A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK14112433.4A 2006-02-09 2014-12-10 Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases -1 HK1198919A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77146506P 2006-02-09 2006-02-09
US77365406P 2006-02-16 2006-02-16

Publications (1)

Publication Number Publication Date
HK1198919A1 true HK1198919A1 (en) 2015-06-19

Family

ID=38345545

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112433.4A HK1198919A1 (en) 2006-02-09 2014-12-10 Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases -1

Country Status (13)

Country Link
US (3) US20090304604A1 (xx)
EP (3) EP2740487B1 (xx)
AU (2) AU2007213343B2 (xx)
BR (2) BRPI0707635A2 (xx)
CA (2) CA2641875C (xx)
DK (1) DK1981572T3 (xx)
ES (2) ES2399449T3 (xx)
HK (1) HK1198919A1 (xx)
MX (2) MX2008010173A (xx)
PL (1) PL1981572T3 (xx)
PT (1) PT1981572E (xx)
RU (2) RU2433841C2 (xx)
WO (2) WO2007091267A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2740487B1 (en) * 2006-02-09 2018-02-28 Kamada Ltd. Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases
EP2211956A4 (en) 2007-10-10 2014-07-09 Parion Sciences Inc DISPOSAL OF OSMOLYTES WITH A NOSE CANNULA
ES2679819T3 (es) 2009-11-03 2018-08-31 Grifols Therapeutics Inc. Composición, método y kit para inhibidor de alfa-1 proteinasa
AU2010324839B2 (en) 2009-11-24 2015-02-19 Grifols Therapeutics Inc. Lyophilization methods, compositions, and kits
AU2012267938B2 (en) 2011-06-07 2017-05-04 Parion Sciences, Inc. Methods of treatment
US8945605B2 (en) * 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
WO2013096458A1 (en) * 2011-12-19 2013-06-27 Gtc Biotherapeutics, Inc. Recombinant human alpha-1-antitrypsin for the treatment of inflammatory disorders
SG2014012066A (en) 2011-12-30 2014-09-26 Grifols Sa Alpha1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
WO2013175007A1 (en) * 2012-05-25 2013-11-28 Inserm Agents for treating cystic fibrosis
BR112014030569B1 (pt) 2012-06-08 2021-12-28 Koninklijke Philips N.V Método de monitoramento da função pulmonar de um paciente usando um sistema que tem um aparelho respiratório e uma unidade de processamento, e sistema para uso no monitoramento da função pulmonar de um paciente
US10034921B2 (en) 2013-02-13 2018-07-31 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
WO2016087582A1 (en) * 2014-12-03 2016-06-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and pharmaceutical compositions for the prevention and/or treatment of acute exacerbations of chronic obstructive pulmonary disease
PT3463280T (pt) 2016-05-31 2022-10-07 Polyphor Ag Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis
EP3348293A1 (en) 2017-01-17 2018-07-18 Carebay Europe Ltd. Medicament delivery device
WO2018154568A1 (en) * 2017-02-21 2018-08-30 Kamada Ltd. Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases
PT3723790T (pt) * 2017-12-12 2024-05-10 Kamada Ltd Métodos de indução de tolerância imunitária e de redução da resposta de anticorpos antifármacos
WO2020157752A1 (en) * 2019-01-29 2020-08-06 Kamada Ltd Pharmaceutical aerosol composition
WO2021198116A1 (en) 2020-04-01 2021-10-07 UNION therapeutics A/S Formulation
WO2021198115A1 (en) 2020-04-01 2021-10-07 UNION therapeutics A/S Treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4697003A (en) * 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US5114917A (en) 1986-12-24 1992-05-19 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化
US5518179A (en) * 1991-12-04 1996-05-21 The Technology Partnership Limited Fluid droplets production apparatus and method
US5780440A (en) 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
PL343276A1 (en) * 1998-03-16 2001-08-13 Inhale Therapeutic Syst Aerosolized active agent delivery
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
US6462180B1 (en) * 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
EP1295647A1 (en) 2001-09-24 2003-03-26 The Technology Partnership Public Limited Company Nozzles in perforate membranes and their manufacture
ATE463304T1 (de) 2002-08-02 2010-04-15 Pari Pharma Gmbh Vorrichtung zur erzeugung von flüssigkeitströpfchen
DE10257381B4 (de) 2002-12-09 2006-09-14 Pari GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung
WO2005027821A2 (en) 2003-09-22 2005-03-31 Kamada Ltd. Large scale preparation of alpha-1 proteinase inhibitor and use thereof
ATE530165T1 (de) * 2003-11-14 2011-11-15 Baxter Int Alpha1-antitrypsin-zusammensetzungen und behandlungsverfahren unter verwendung dieser zusammensetzungen
US7914771B2 (en) 2004-03-09 2011-03-29 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
EP2740487B1 (en) * 2006-02-09 2018-02-28 Kamada Ltd. Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases

Also Published As

Publication number Publication date
WO2007091267A2 (en) 2007-08-16
AU2007213344A1 (en) 2007-08-16
RU2472524C2 (ru) 2013-01-20
BRPI0707634A2 (pt) 2011-05-10
DK1981572T3 (da) 2013-03-04
ES2664624T3 (es) 2018-04-20
EP1981572A2 (en) 2008-10-22
RU2433841C2 (ru) 2011-11-20
PL1981572T3 (pl) 2013-05-31
AU2007213343A1 (en) 2007-08-16
EP2740487B1 (en) 2018-02-28
US7973005B2 (en) 2011-07-05
CA2641875A1 (en) 2007-08-16
WO2007091266A3 (en) 2007-11-15
EP1981572B1 (en) 2012-11-21
CA2641875C (en) 2016-10-04
MX2008010173A (es) 2009-02-12
US20090131305A1 (en) 2009-05-21
WO2007091266A2 (en) 2007-08-16
US20090304604A1 (en) 2009-12-10
CA2641872A1 (en) 2007-08-16
EP1981531A2 (en) 2008-10-22
RU2008135580A (ru) 2010-03-20
MX2008010172A (es) 2009-09-07
ES2399449T3 (es) 2013-04-01
RU2008135582A (ru) 2010-03-20
BRPI0707635A2 (pt) 2011-05-10
EP2740487A1 (en) 2014-06-11
AU2007213343B2 (en) 2012-09-13
WO2007091267A3 (en) 2007-11-22
AU2007213344B2 (en) 2012-11-15
US20120211005A1 (en) 2012-08-23
PT1981572E (pt) 2013-02-26

Similar Documents

Publication Publication Date Title
HK1198919A1 (en) Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases -1
IL216511A0 (en) Janus kinase inhibitor compounds and methods
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
HK1147476A1 (zh) 作為 烟魯綠 激酶抑制劑的 -吡唑基- -芳基嘧啶- -胺類以及 -吡唑基- -雜芳基嘧啶- -胺類
EP2038452A4 (en) METHOD FOR PRODUCING A SUPERHYDROPHOBIC SURFACE AND THEREOF FIXED WITH SUPERHYDROPHOBIC SURFACE STRUCTURE
PL2180938T3 (pl) Sposób oczyszczania gazu odlotowego
PL1903019T3 (pl) Sposób wytwarzania izoolefin
HK1186622A1 (zh) 加速切換
IL197381A0 (en) Kinase inhibitor
IL202046A0 (en) Process for the manufacture of p4o6
EP2103590A4 (en) METHOD FOR PRODUCING AN ACROLEINE AND GLYCERINE-CONTAINING COMPOSITION
IL192745A0 (en) Use of kcnq-openers for treating or reducing the symptoms of schizophrenia
EP2032373A4 (en) OUTER HOUSING FOR A REFRIGERATOR AND MANUFACTURING METHOD THEREFOR
PL1986795T3 (pl) Sposób tłumienia wpływu mimośrodowości walców
EP2051731A4 (en) METHOD FOR REDUCING THE MASTITIS PRESENCE
IL243809A0 (en) Process for the production of γ-ketosulfide compound and γ-ketosulfide compounds
GB0603522D0 (en) Kinase inhibition
ZA201000802B (en) Process for the preparation of alfuzosin hydrochloride
IL193319A0 (en) Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases
PL380473A1 (pl) Sposób wytwarzania modyfikowanego kaolinu
ZA200903936B (en) Method for the production of an agent against an infectuous disease
HK1134925A1 (en) Method for the production of benzofuran-2-carboxamides
ZA201004090B (en) Methods for the inhibition of scarring
PL381076A1 (pl) Sposób wytwarzania polimetylenomoczników
PL380878A1 (pl) Sposób wytwarzania biohumusu